Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 1
1967 3
1968 4
1970 2
1971 3
1973 2
1974 2
1976 2
1977 1
1979 1
1980 2
1981 2
1983 2
1984 4
1987 5
1988 3
1989 5
1990 2
1991 2
1992 4
1993 2
1994 8
1995 5
1996 10
1997 6
1998 5
1999 9
2000 11
2001 15
2002 6
2003 17
2004 11
2005 17
2006 25
2007 16
2008 23
2009 19
2010 12
2011 9
2012 13
2013 23
2014 12
2015 16
2016 21
2017 18
2018 22
2019 16
2020 18
2021 25
2022 22
2023 19
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

468 results

Results by year

Filters applied: . Clear all
Page 1
Hereditary hemorrhagic telangiectasia: diagnosis and management from the hematologist's perspective.
Kritharis A, Al-Samkari H, Kuter DJ. Kritharis A, et al. Haematologica. 2018 Sep;103(9):1433-1443. doi: 10.3324/haematol.2018.193003. Epub 2018 May 24. Haematologica. 2018. PMID: 29794143 Free PMC article. Review.
Hereditary hemorrhagic telangiectasia (HHT), also known as Osler-Weber-Rendu syndrome, is an autosomal dominant disorder that causes abnormal blood vessel formation. The diagnosis of hereditary hemorrhagic telangiectasia is clinical, base …
Hereditary hemorrhagic telangiectasia (HHT), also known as Osler-Weber-Rendu syndrome, is an autosomal dominant disorde …
TGF-β Signaling in Control of Cardiovascular Function.
Goumans MJ, Ten Dijke P. Goumans MJ, et al. Cold Spring Harb Perspect Biol. 2018 Feb 1;10(2):a022210. doi: 10.1101/cshperspect.a022210. Cold Spring Harb Perspect Biol. 2018. PMID: 28348036 Free PMC article. Review.
Genetic studies in animals and humans indicate that gene mutations that functionally perturb transforming growth factor beta (TGF-beta) signaling are linked to specific hereditary vascular syndromes, including Osler-Rendu-Weber disease or hereditary hemorrhagic …
Genetic studies in animals and humans indicate that gene mutations that functionally perturb transforming growth factor beta (TGF-beta) sign …
Hereditary hemorrhagic telangiectasia: systemic therapies, guidelines, and an evolving standard of care.
Al-Samkari H. Al-Samkari H. Blood. 2021 Feb 18;137(7):888-895. doi: 10.1182/blood.2020008739. Blood. 2021. PMID: 33171488 Free article. Review.
Hereditary hemorrhagic telangiectasia (HHT) management is evolving because of the emergence and development of antiangiogenic therapies to eliminate bleeding telangiectasias and achieve hemostasis. ...
Hereditary hemorrhagic telangiectasia (HHT) management is evolving because of the emergence and development of antiangi …
How we diagnose and treat iron deficiency anemia.
Auerbach M, Adamson JW. Auerbach M, et al. Am J Hematol. 2016 Jan;91(1):31-8. doi: 10.1002/ajh.24201. Epub 2015 Nov 17. Am J Hematol. 2016. PMID: 26408108 Free article. Review.
Oral iron is considered front line therapy except for conditions such as gastric bypass, heavy uterine bleeding, inflammatory bowel disease, and hereditary hemorrhagic telangiectasia. Oral iron has many unpleasant side effects, resulting in low patient adhere …
Oral iron is considered front line therapy except for conditions such as gastric bypass, heavy uterine bleeding, inflammatory bowel disease, …
Anticoagulation and antiplatelet therapy in hereditary hemorrhagic telangiectasia: A scoping review.
Zhang E, Virk ZM, Rodriguez-Lopez J, Al-Samkari H. Zhang E, et al. Thromb Res. 2023 Jun;226:150-155. doi: 10.1016/j.thromres.2023.04.017. Epub 2023 May 3. Thromb Res. 2023. PMID: 37163869 Review.
INTRODUCTION: Data describing safety and tolerability of anticoagulation and antiplatelet therapy in hereditary hemorrhagic telangiectasia (HHT), the second-most-common inherited bleeding disorder, is limited. ...
INTRODUCTION: Data describing safety and tolerability of anticoagulation and antiplatelet therapy in hereditary hemorrhagic …
Hereditary Hemorrhagic Telangiectasia.
Kühnel T, Wirsching K, Wohlgemuth W, Chavan A, Evert K, Vielsmeier V. Kühnel T, et al. Otolaryngol Clin North Am. 2018 Feb;51(1):237-254. doi: 10.1016/j.otc.2017.09.017. Otolaryngol Clin North Am. 2018. PMID: 29217066 Review.
Hereditary hemorrhagic telangiectasia (HHT) describes the presenting manifestations of a disorder that is characterized by pathologic blood vessels. ...
Hereditary hemorrhagic telangiectasia (HHT) describes the presenting manifestations of a disorder that is characterized …
Treatments of Epistaxis in Hereditary Hemorrhagic Telangiectasia: Systematic Review and Network Meta-Analysis.
Chitsuthipakorn W, Hoang MP, Kanjanawasee D, Seresirikachorn K, Snidvongs K. Chitsuthipakorn W, et al. Curr Allergy Asthma Rep. 2023 Dec;23(12):689-701. doi: 10.1007/s11882-023-01116-8. Epub 2023 Nov 23. Curr Allergy Asthma Rep. 2023. PMID: 37995018 Review.
PURPOSE OF REVIEW: To analyze and compare the effects of epistaxis treatments for Hereditary Hemorrhagic Telangiectasia (HHT) patients. RECENT FINDINGS: Of total of 21 randomized controlled trials (RCT), the data from 15 RCTs (697 patients, 7 treatments: timo …
PURPOSE OF REVIEW: To analyze and compare the effects of epistaxis treatments for Hereditary Hemorrhagic Telangiectasia …
Hereditary Hemorrhagic Telangiectasia.
Parambil JG. Parambil JG. Clin Chest Med. 2016 Sep;37(3):513-21. doi: 10.1016/j.ccm.2016.04.013. Epub 2016 Jun 10. Clin Chest Med. 2016. PMID: 27514597 Review.
Hereditary hemorrhagic telangiectasia (HHT) is an underrecognized and underdiagnosed autosomal-dominant angiodysplasia that has an estimated prevalence of 1 in 5000 individuals, with variable clinical presentations even within family members with identical mu …
Hereditary hemorrhagic telangiectasia (HHT) is an underrecognized and underdiagnosed autosomal-dominant angiodysplasia …
Hereditary hemorrhagic telangiectasia.
Chung MG. Chung MG. Handb Clin Neurol. 2015;132:185-97. doi: 10.1016/B978-0-444-62702-5.00013-5. Handb Clin Neurol. 2015. PMID: 26564080 Review.
Hereditary hemorrhagic telangiectasia (HHT) also known as Osler-Weber-Rendu syndrome, is an autosomal dominant disorder that is characterized by multiple arteriovenous malformations (AVMs) involving the skin, mucosal surfaces, and internal organs. ...
Hereditary hemorrhagic telangiectasia (HHT) also known as Osler-Weber-Rendu syndrome, is an autosomal dominant disorder …
Pulmonary arteriovenous malformations.
Tellapuri S, Park HS, Kalva SP. Tellapuri S, et al. Int J Cardiovasc Imaging. 2019 Aug;35(8):1421-1428. doi: 10.1007/s10554-018-1479-x. Epub 2018 Nov 1. Int J Cardiovasc Imaging. 2019. PMID: 30386957 Review.
Pulmonary arteriovenous malformation, a condition most commonly associated with hereditary hemorrhagic telangiectasia, is an abnormal communication between the pulmonary artery and pulmonary vein without an intervening capillary communication. ...
Pulmonary arteriovenous malformation, a condition most commonly associated with hereditary hemorrhagic telangiectasia, …
468 results